The pooled data of two studies showed that high Ezrin expression was significantly associated with overall survival (OS) for gastric cancer (HR = 1.88, 95% CI = 1.33–2.66, P = 0.000), and no significant heterogeneity was observed (I2 = 0.0%, P = 0.446) (Table 2). This evidence concerns the gene EZR and gastric cancer.